secwatch.observer — SEC 8-K summary
======================================

Issuer:     Moderna, Inc. (MRNA)
CIK:        0001682852
Form:       8-K
Filed at:   2022-04-11T23:59:59+00:00
Accession:  0001193125-22-101074
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Moderna appoints Jorge Gomez as CFO; David Meline to retire effective May 9, 2022
--------------------------------------------------------------------------------

- Jorge Gomez appointed CFO effective May 9, 2022, reporting to CEO Stéphane Bancel.
- Gomez previously CFO at Dentsply Sirona (Nasdaq: XRAY) and held CFO roles at Cardinal Health.
- Current CFO David Meline retiring; will serve as consultant through July 2024 with continued equity vesting.
- Gomez receives $700k base salary, $500k signing bonus, and equity grant valued at $4M vesting over four years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1682852/000119312522101074/0001193125-22-101074-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1682852/000119312522101074/d520384d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-101074

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer